Shipra Gandhi, MD, Pallawi Torka, MD

In this article, Shipra Gandhi, MD, Pallawi Torka, MD, and Francisco J. Hernandez Ilizaliturri, MD summarize the current clinical development of these novel agents in lymphoid malignancies.

In this review, our authors discuss the mechanism of action and clinical development of various checkpoint inhibitors in lymphoma.